Fox Run Management L.L.C. Has $1.34 Million Holdings in The Cigna Group (NYSE:CI)

Fox Run Management L.L.C. cut its position in shares of The Cigna Group (NYSE:CI - Free Report) by 25.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 4,854 shares of the health services provider's stock after selling 1,652 shares during the quarter. Fox Run Management L.L.C.'s holdings in The Cigna Group were worth $1,340,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. TCTC Holdings LLC acquired a new stake in The Cigna Group in the 4th quarter valued at about $25,000. Prospera Private Wealth LLC bought a new stake in shares of The Cigna Group in the 3rd quarter worth approximately $37,000. Collier Financial acquired a new stake in The Cigna Group during the fourth quarter valued at approximately $32,000. ORG Wealth Partners LLC bought a new stake in The Cigna Group during the fourth quarter worth approximately $34,000. Finally, Compagnie Lombard Odier SCmA acquired a new position in The Cigna Group in the fourth quarter worth approximately $37,000. Institutional investors own 86.99% of the company's stock.

The Cigna Group Price Performance

NYSE CI traded down $3.06 on Tuesday, reaching $317.35. The company's stock had a trading volume of 285,969 shares, compared to its average volume of 1,564,847. The firm has a market cap of $86.85 billion, a PE ratio of 25.93, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The business has a 50-day moving average price of $301.62 and a 200 day moving average price of $314.45.

Remove Ads

The Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period last year, the firm earned $6.79 earnings per share. Sell-side analysts expect that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th were given a $1.51 dividend. The ex-dividend date was Wednesday, March 5th. This is a positive change from The Cigna Group's previous quarterly dividend of $1.40. This represents a $6.04 dividend on an annualized basis and a yield of 1.90%. The Cigna Group's payout ratio is 49.35%.

Insiders Place Their Bets

In other The Cigna Group news, CEO David Cordani sold 26,527 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the sale, the chief executive officer now owns 127,767 shares of the company's stock, valued at $39,367,568.04. This represents a 17.19 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Elder Granger sold 2,376 shares of the business's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $310.35, for a total transaction of $737,391.60. Following the completion of the transaction, the director now directly owns 5,471 shares of the company's stock, valued at approximately $1,697,924.85. This represents a 30.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 43,751 shares of company stock valued at $13,603,991. 0.60% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on CI shares. Stephens reduced their price objective on The Cigna Group from $410.00 to $380.00 and set an "overweight" rating for the company in a research note on Friday, January 31st. Morgan Stanley decreased their price target on The Cigna Group from $403.00 to $379.00 and set an "overweight" rating for the company in a research report on Friday, January 31st. Truist Financial cut their price objective on The Cigna Group from $390.00 to $375.00 and set a "buy" rating on the stock in a report on Tuesday, February 4th. Oppenheimer decreased their target price on shares of The Cigna Group from $400.00 to $375.00 and set an "outperform" rating for the company in a report on Friday, January 31st. Finally, UBS Group cut their price target on shares of The Cigna Group from $410.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, February 3rd. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $373.25.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.